Clinical trial
The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study
NCT00407381 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00407381 |
|---|---|
| Title | The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study |
| Official title | Ranibizumab for Edema of the Macula in Diabetes: a Phase 2 Study ( The Read-2 Study) |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Juvenile Diabetes Research Foundation Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug, Procedure |
| Interventions | Ranibizumab, Laser photocoagulation |
| Enrollment | 126 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2011 |
| First posted | Dec 5, 2006 |
| Last update posted | Mar 31, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: